Inflammatory Bowel Diseases (IBD) have silently and relentlessly pervaded the lives of millions of people worldwide, causing debilitating effects on human health that extend far beyond their visible symptoms.
IBD has emerged as an urgent global health concern, demanding immediate attention from medical communities, policymakers, and society as a whole. In the United States alone, an estimated 3 million people suffer from Crohn’s disease, ulcerative colitis, and other chronic inflammation of the gastrointestinal tract, and these conditions impact more than 10 million people worldwide.
Fortunately, there is a dedicated community of researchers and healthcare professionals advancing the field and improving outcomes for patients.
At the recent Advances in Inflammatory Bowel Diseases (AIBD) meeting, held December 14-16 in Orlando, three of these visionary leaders were recognized. Each year, the Bruce and Cynthia Sherman Charitable Foundation awards three Sherman Prizes to IBD clinicians, researchers, surgeons, and academics, recognizing exceptional and pioneering contributions that transform the care of people with IBD.
